Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

November has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For instance, the Joint Commission, Silicon Valley Bank and Regard named new executives. There were also layoffs at organizations including Oak Street Health, Providence and Optum. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first…

Read More

Real-World Data Salvage Biohaven Drug, Paving Way for FDA Filing in Neuro Disease With No Approved Meds

Biohaven’s troriluzole, which initially failed a pivotal study in spinocerebellar ataxia, is now being readied for an FDA submission in this rare neurodegenerative disease. The turnabout is based on positive results from a new study that incorporated real-world evidence. The post Real-World Data Salvage Biohaven Drug, Paving Way for FDA Filing in Neuro Disease With…

Read More

Hospital Margins Squeeze as Costs Outpace Revenue Growth

Hospitals are still on quite fragile financial footing if you look beneath the surface, according to new Kaufman Hall data. Rising costs, uneven patient volumes, and ongoing reimbursement and payer mix pressures continue to limit the sector’s financial recovery. The post Hospital Margins Squeeze as Costs Outpace Revenue Growth appeared first on MedCity News.

Read More

Vaccine choice = more measles infection

Texas is moving to allow for more freedom of choice with respect to receipt of vaccines. The Economist reports: Texas legislators meeting in Austin, the state capital, are debating new laws to relax vaccine rules, urged on by Texans for Vaccine Choice (TFVC). On February 18th activists in “Come and Make Me” shirts took to…

Read More